Ana López-Machado

Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona

Materials Science · Physical Sciences

11h-index2.5kcitations13works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(3), Alzheimer's disease research and treatments(2), Advancements in Transdermal Drug Delivery(2), RNA Interference and Gene Delivery(2), Advanced Drug Delivery Systems(2)

Publications13 total

Colloidal hydrogel systems of thymol-loaded PLGA nanoparticles designed for acne treatment
Colloids and Surfaces B Biointerfaces·2023· 10 citedOpen Access
Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes
International Journal of Pharmaceutics·2021· 35 citedOpen Access
Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation
Pharmaceutics·2021· 69 citedOpen Access
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
Journal of Nanobiotechnology·2020· 80 citedOpen Access
Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases
Nanomedicine·2020· 133 cited
Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges
Current Pharmaceutical Design·2020· 20 cited
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
Nanomaterials·2020· 1.4k citedOpen Access
Trends in Atopic Dermatitis—From Standard Pharmacotherapy to Novel Drug Delivery Systems
International Journal of Molecular Sciences·2019· 73 citedOpen Access
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I
Pharmaceuticals·2019· 176 citedOpen Access
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
Pharmaceutics·2019· 184 citedOpen Access
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II
Journal of Clinical Medicine·2019· 69 citedOpen Access
Nanopartícules polimèriques d'epigalocatequina-3-galat, un enfocament nanotecnològic per tractar la malaltia d'Alzheimer
2019
Current Applications of Nanoemulsions in Cancer Therapeutics
Nanomaterials·2019· 258 citedOpen Access

Frequent Co-authors

María L. García(12), Elena Sánchez‐López(11), Eliana B. Souto(11), Marta Espina(9), Amanda Cano(8), Miren Ettcheto(6), Antoni Camins(6), Amélia M. Silva(5), Antonello Santini(3), João Dias-Ferreira(3), Selma B. Souto(3), Natalia Díaz‐Garrido(3), Josefa Badı́a(3), Laura Baldomà(3), Ana Cristina Calpena(3), Lorena Bonilla(2), Ruth Galindo(2), Raquel Vieira(2), Patrícia Severino(2), Sajan Jose(2)